Anbio Biotechnology Class A Ordinary Shares
NNNNNASDAQ · Healthcare · Medical - Instruments & SuppliesAnbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationa…
$3.82+0.53%
报价 2026-11-13
市值
$167.7M
EV
$159.5M
PE (TTM)
19.7x
预期 PE
–
52 周区间距高点 -90.7%
$3.13$41.11
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NNNNAnbio Biotechnology Class A Ordinary Shares | $167.7M | +0.5% | – | 86.1% | 19.7x | 24.6x | – | |
| SMTISanara MedTech Inc. | $297.1M | -0.6% | +14.4% | 91.3% | – | 37.4x | 71.2x | |
| INFUInfuSystem Holdings, Inc. | $294.9M | -0.5% | +1.1% | 57.5% | 29.7x | 12.0x | 13.2x | |
| OSUROraSure Technologies, Inc. | $250M | +1.7% | +4.4% | 41% | – | – | – | |
| PDEXPro-Dex, Inc. | $210.1M | -2.6% | 0.0% | 32.5% | 18.8x | 13.5x | 20.8x | |
| UTMDUtah Medical Products, Inc. | $205M | -2.3% | – | 52.9% | 19.1x | 7.4x | 27.0x | |
| KRMDKORU Medical Systems, Inc. | $160.5M | +0.3% | +18.8% | 63.2% | – | – | – | |
| NYXHNyxoah S.A. | $91.6M | +0.5% | – | 51.3% | – | – | – | |
| STXSStereotaxis, Inc. | $84.5M | -0.8% | +20.1% | 55.6% | – | – | – | |
| 同行中位数 | – | – | +9.4% | 54.2% | 19.1x | 12.8x | 23.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。